Maas Group Holdings Ltd Secures $855m Firmus Order and Lifts FY26 EBITDA Guidance [VIDEO]
Maas Group lifts its Maas Group FY26 earnings guidance increase to $300m–$310m EBITDA, anchored by an $855 million electrical infrastructure order for AI developer Firmus and a further $300 million equity stake in the company.
Key Takeaways
- Maas Group has lifted FY26 Group underlying EBITDA guidance to $300m–$310m, up from the $250m–$280m range issued in May 2026, driven by a Firmus fair value uplift and strong divisional performance.
- JLE Group has secured an $855 million purchase order from Firmus for modular electrical infrastructure to be delivered over 18 months, pushing total JLE work in hand past $1.2 billion.
- MGH has committed a further $300 million to acquire Firmus shares and preference shares at $230 each, bringing its total investment to $410 million for approximately a 3.2% stake in the AI infrastructure developer.
- The $1.703 billion sale of Construction Materials to Heidelberg Materials Australia has received ACCC clearance, with settlement expected in October 2026 and $1.583 billion payable at that date.
- Audited FY26 results are scheduled for release on 20 August 2026, with the HMA settlement and further Firmus 3.3GW roll-out tender outcomes serving as the next key catalysts for investors.
![Aland Equity Group Ltd Launches Capital Light Model With Elm Grove Heights Deal [VIDEO]](https://media.stockwirex.com/AEG-Elm-Grove-Heights.jpg)
![Imugene Ltd Notches Third Response in Azer Cel BTKi Cohort [VIDEO]](https://media.stockwirex.com/laboratory_with_signage.jpg)
![4DMEDICAL Ltd Eyes US$20M Veterans Lung Imaging Pilot in Bipartisan Bill [VIDEO]](https://media.stockwirex.com/veo32Fnanobanana2F50ee8fd8-6e27-47e9-8f8b-bc44aecfe8a02Fimage_0.jpg)
Breaking ASX Alerts Direct to Your Inbox
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
- Breaking ASX announcements delivered within minutes
- Alerts delivered with expert analysis
- Optional text alert for subscribers
- No spam policy, unsubscribe any time
About the Publisher
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
Disclaimer
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X Pty Ltd (CAR No. 001 322 642) is a Corporate Authorised Representative of ShareX Pty Ltd (AFSL No. 519872), regulated by the Australian Securities and Investments Commission (ASIC). StockWire X is authorised to provide general financial product advice in relation to basic deposit products, securities, and managed investment schemes.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
Disclosure
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
Disclaimer